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Abstract. To elucidate regulatory mechanism(s) un- 
derlying differentiation of osteoblasts, we examined in- 
volvement of helix-loop-helix (HLH)-type transcription 
factors in osteoblast-specific expression of a pheno- 
typic marker gene which encodes osteocalcin, a major 
noncollagenous bone matrix protein, exclusively ex- 
pressed in osteoblasts. Overexpression of a dominant 
negative HLH protein, Id-1, decreased the activity of 
the 1.1-kb osteocalcin gene promoter cotransfected into 
rat osteoblastic osteosarcoma ROS17/2.8 cells. Analysis 
of deletion mutants revealed that a 264-bp fragment of 
osteocalcin promoter (-198 to  +66) was sufficient for 
the Id-l-dependent suppression. Furthermore, the ac- 
tivity of the same promoter fragment (-198 to  +66) 
was enhanced when antisense Id-1 expression vector 
was cotransfected. This osteocalcin gene promoter re- 
gion contains two sites of an E-box motif, a consensus 
binding site for HLH proteins, which we refer to as 
OCE1  (CACATG, at  -102) and OCE2 (CAGCTG,  at 
-149), respectively. Mutagenesis in OCE1  but not 
OCE2 led to greater than 50%  reduction in transcrip- 
tional activity of the osteocalcin gene promoter. Elec- 
trophoresis mobility shift assay indicated that factors 
in nuclear extracts prepared from ROS17/2.8 cells 
bound to the 30-bp oligonucleotide probe containing 
the E-box motif of OCE1.  This binding was competed 
out by OCE1  oligonucleotide but neither by OCmE1 
oligonucleotide in which E-box motif was mutated nor 
by OCE2. The OCEl-binding activity in the nuclear 
extracts of ROS17/2.8 cells was reduced by 70%  when 
bacterially expressed Id-1 protein was added to the 
reaction mixture, suggesting the involvement of HLH 
proteins in the DNA/protein complex formation. In 
contrast to the osteoblast-like cells, OCEl-binding ac- 
tivity in the nuclear extracts of C3H10T1/2 fibroblasts 
was very low. However, when these fibroblasts were 
treated with recombinant human bone morphogenetie 
protein-2 which induced expression of osteocalcin 
as well as other phenotypic markers of osteoblasts, 
OCEl-binding activity was increased ,x,40-fold,  indi- 
cating that OCE1  would be involved in the tissue- 
specific expression of the osteocalcin gene. These 
findings indicated for the first time that osteoblast- 
specific gene transcription is regulated via the interac- 
tion between certain E-box binding transcription fac- 
tor(s) in osteoblasts and the OCE1  sequence in the 
promoter region of the osteocalcin gene. 
D 
VELOPMENT and differentiation  of cells  are under 
the control of various classes of transcription factors 
which have been identified through genetic and bio- 
chemical means. Some of these factors have been shown to 
play key roles during cell differentiation process. Extracellu- 
lar signals including hormones, growth factors,  cytokines, 
or extraceUular matrix components as well as their intracel- 
lular mediators regulate cell differentiation or expression of 
phenotypes by modulating the activities of transcription fac- 
tors involved in expression of respective genes (for review 
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see Stein and Lian, 1993). Osteoblasts are thought to be de- 
rived from so-called  undifferentiated  mesenchymal cells. 
Upon differentiation, osteoblasts express phenotype-related 
genes encoding proteins  such as osteocalcin,  osteopontin, 
alkaline phosphatase,  type I collagen, parathyroid hormone 
receptor, and so on (for review see Rodan and Rodan, 1984). 
Among those, osteocalcin is considered to be the only pro- 
tein expressed  specifically  in  osteoblasts  (for review  see 
Gundberg et al.,  1984). 
Osteocalcin (bone ~,-carboxyglutamic acid-containing pro- 
tein) is the most abundant noncollagenous matrix protein in 
bone and is produced exclusively by relatively mature os- 
teoblasts (for reviews see Gundberg et al., 1984; Hauschka, 
1986). Serum osteocalcin level correlates well with histo- 
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used clinically to estimate the level of bone turnover (for re- 
view see Lian,  1988).  Osteocalcin has been suggested to 
control hydroxyapatite crystal growth and seems to consti- 
tute a signal for osteoclastic bone resorption. Resorption of 
subcutaneously implanted bone particles is impaired when 
the amount of osteocalcin in bone is reduced, and in vitro 
experiments also show that osteocalcin is a chemoattractant 
for monocytes, which are thought to be the precursors of os- 
teoclasts (for reviews  see Hauschka, 1986;  Lian,  1988). 
Cell type-specific gene expression in many types of cells 
are controlled at the level of transcription. Transcriptional 
regulation also plays a key role in osteocalcin gene expres- 
sion and the gene has been used as a model in the study of 
cell type-specific gene expression in osteoblasts (for review 
see Stein and Lian, 1993). Several transcriptional regulators 
have been reported to bind DNA elements that are located 
in the Y-flanking region of rat osteocalcin gene and to con- 
trol its transcription in response to physiological stimuli. In 
the  rat  osteocalcin  gene,  Lian  et  al.  (1989) previously 
identified in the proximal promoter region a 24-nucleotide 
sequence,  designated  as  osteocalcin box  (-76  to  -99), 
which contains a CCAAT motif as a central element and is 
required for the basal level of osteocalcin gene transcription. 
A similar sequence was identified in the promoter region of 
human osteocalcin gene (Lian et al., 1989). Another regula- 
tory region in rat osteocalcin gene is the TATA box (-44 to 
-23), which contains a consensus glucocorticoid-responsive 
element (Heinrichs et al.,  1993).  A  vitamin D-responsive 
element and AP-1 site have been also identified in human 
and rat osteocalcin genes (Morrison et al., 1989; Demay et 
al.,  1990;  Ozono et al.,  1990).  Recently, mapping studies 
were undertaken to characterize the tumor necrosis factor 
o~-responsive element [-522 to -511] in the human osteo- 
calcin promoter (Li and Stashenko,  1993).  Several other 
putative cis-acting elements involved in the transcriptional 
regulation were identified by computer analysis, including 
AP2- and NFl-binding sites and cyclic AMP-responsive ele- 
ment (Yoon et al.,  1988;  Lian et al.,  1989). 
Helix-loop-helix (HLH)  ~ family proteins have been im- 
plicated in transcriptional regulation of cell type determi- 
nation  and  differentiation and  ~40  members  have  been 
reported to belong to this class.  These members of basic 
HLH  (bHLH)  family proteins  bind  to  a  core  sequence, 
CANNTG, which is also referred to as an E-box motif, ini- 
tially identified in the immunoglobulin heavy chain gene en- 
hancer (for review see Murre and Baltimore, 1992).  Since 
then, several  other functional E-box sites have been iden- 
tified in the 5'-flanldng regions of genes expressed in a cell 
type-specific manner. Those include muscle creatine kinase 
gene (Buskin and Hauschka,  1989)  as well as acetylcho- 
line receptor ot subunit gene (Piette et al., 1990) in skeletal 
muscle,  insulin gene in pancreatic /5 cells (Cordle et al., 
1991), secretin gene in islet cells (Wheeler et al., 1992), and 
proopiomelanocortin gene in pituitary cells (Therrien and 
Drouin,  1993).  bHLH proteins can be divided into at least 
two classes: those that are expressed in a broad spectrum of 
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tissues  and  cell  types  and  those  expressed  in  a  rissue- 
restricted fashion (Murre and Baltimore,  1992).  E-box se- 
quences have not yet been implicated in osteoblast-specific 
expression of osteocalcin gene and so far, only ubiquitously 
expressed  HLH genes  such  as  E2A  and Id-1 have  been 
reported to be expressed in osteoblasts or osteoblast-like 
cells. Expression of Id gene in osteoblastic cells have been 
shown to be under the regulation of calcitrophic hormones 
and cytokines (Ogata and Noda,  1991; Kawaguchi et al., 
1992).  To elucidate the possibility of the  involvement of 
bHLH proteins in osteoblast-specific gene expression, we 
examined the contribution of E-box sequences to the activity 
of the promoter and tissue specific expression of the os- 
teocalcin gene in osteoblasts. In the present work, we show 
that E-box sequence 1 (OCE1) in rat osteocalcin gene is in- 
volved in HLH molecule-mediated expression of the gene in 
osteoblasts by deletion and site-directed mutagenesis analy- 
ses  of the promoter region.  Furthermore, electrophoresis 
mobility shift assay (EMSA) experiments indicated the for- 
marion of osteoblast-specific protein/DNA complexes with 
this OCE1 sequence, and this binding activity was induced 
in C3H10T1/2 fibroblasts by recombinant human bone mor- 
phogenetic protein 2 (rhBMP-2) treatment which induces ex- 
pression of osteocalcin gene in these cells. Thus, this study 
presents an evidence that the E-box sequence, OCE1,  and 
transcription factors interacting with this motif are involved 
in osteoblast-specific osteocalcin gene transcription. 
Materials and Methods 
Cell Culture 
Rat osteoblastic osteosarcoma ROS17/2.8 cells (Majeska et al., 1980) were 
kindly provided by Dr.  G.  Rodan (Merck  Research  Laboratories,  West 
Point, PA) and were maintained in modified F-12 medium (Gibco Laborato- 
ries, Grand Island, NY) supplemented with 5 % FBS (Gibco Laboratories). 
C3H10TI/2 fibroblasts were obtained from RIKEN Cell Bank (Tsukuba, Ja- 
pan) (Reznikoff  et al., 1973). C3H10T1/2 cells were grown in DME (Gibco 
Laboratories)  supplemented with 5% FBS. Ceils were cultured in a hu- 
midified atmosphere of 95 % air and 5 % CO2 at 37°C. 
Construction of  Plasmids 
One  of the  promoter constructs  pOCI094CAT  containing  a  fragment 
(-1094 to +147) of the rat osteocalcin gene linked to the chloramphenicol 
acetyltransferase (CAT) gene used in this paper was previously described 
(Yoon et al., 1988) and was kindly provided by Dr. G. Redan (Merck Re- 
search Laboratories). Several 5' deletion mutants of  the rat osteocalcin gene 
promoter  constructs,  pOC431CAT, pOC198CAT, and  pOC98CAT, were 
generated as follows. Promoter fragments of AB (-431 to +66) CB (-198 
to +66), and DB (-99 to +66) were generated by PCR using primers (A3, 
C2,  D2, and B3), digested with XbaI and HindIII, and then ligated into 
pGEM4Z-CAT  (a  gift  from  M.  Young, National  Institutes  of Health, 
Bethesda, MD) after digestion of the vector with XbaI and HindlII.  The 
PCR-oligonucleotide  sequences  used  in  deletion  mutagenesis  were  as 
follows: 
A2, GTAGAGAAGCTTTTCTTCC  "[GC-C~Tr'IGC~ TCCTGC TC  TCA_CGG 
C2,  TGAAC  CAAGC  TTC C  C  CrGCAGC  CTCTGATTGTGTC C  TAC  CCTC 
D2, TGAAAGA  AGC  TrCATGAC  C  C  C  CAATTAGTCC  ~GCATC  T 
B3, "IGGAGG  TC TAGACAGCAGAGTGAGCAGAGAGAGC~  TC  CTCAT 
Site-directed mutagenesis was performed according to the overlap exten- 
sion technique using PCR as described by Ho et al. (1989). In brief, com- 
plementary  oligonucleotides designed to introduce specific mutations by 
PCR were used to generate two DNA fragments having overlapping ends. 
These fragments were combined in a subsequent fusion reaction in which 
the overlapping ends are annealed, allowing the 3' overlap of each strand 
to serve as a primer for Y extension of the complementary  strand.  The 
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fragments were excised with XbaI and HindlII, and then subcloned into the 
XbaI and HindIII sites of pGEM4Z-CAT. The oligonucleotides  used in site- 
directed mutagenesis contain the following mutations (indicated by lower- 
case letters): 
EM-7, TAATIGCJCJGGTgtaacaCGCAATAGG (mutant OCE1  site bottom 
strand) 
EM-8, TGGTGACTGgtaacaCC~GAAG  (mutant OCE2 site bottom 
strand) 
EM-9,  CTATTGCGtgttacACCCCCAATTAG  (mutant  OCE1  site  top 
strand) 
EM-10,  TCGCCCCGGtgttacCAGTCACCAAC  (mutant  OCE2  site  top 
strand) 
The nuelootide  sequences of each deleted and mutated promoter region 
were determined to confirm the absence of mutations introduced by PCR. 
The expression plasmids,  pE: Id (S) sense Id expression vector and pE: 
Id (A) antisense Id expression vector, were a gift from Dr.  H. Weintraub 
(Fred Hutchinson Cancer Research Center,  Seattle,  WA) (Benezra et al., 
1990). 
DNA Transfection, CAT Assay, and Luciferase Assay 
Transfection of plasmid DNA into ROS 17/2.8 was performed using DEAE- 
dextran method (Lopata et ai., 1984). In brief, cells were plated 24 h before 
transfection at a  density of 7  x  10  s  cells per 9.6-em 2 culture well in 
modified F-12 medium supplemented with 5% FBS. The cells were trans- 
fected with 5/~g of reporter plasmid, 1 ~g of pGVC (tramfection efficiency 
control) (Promega Corp., Madison, WI), and 5 #g of expression plasmid 
vectors bearing Id gene as indicated in the figure legends.  The cells were 
exposed to plasmid DNA for 3 h, treated with 10% glycerol for 90 s, and 
were subsequently cultured in fresh medium supplemented with 5 % FBS 
in an atmosphere of 5% C&z and 95% air at 37°C for 48 h. The cells were 
then harvested by scraping into a buffer (150 mM NaCI, 40 mM Tris-HC1, 
and 1 mM EDTA, pH Z5), lysed by three cycles of freezing and thawing 
followed by eentrifugation.  Protein concentrations of the supernatant were 
measured by Coomassie brilliant blue R method (Spector,  1978), and aii- 
quots containing equivalent amounts of protein were incubated in 0.25 M 
Tris-HCl, pH 8.0, and 165 tzg of acetyI-CoA (Sigma Chem. Co., St. Louis, 
MO) and 3.7 kBq of [14C]ehloramphenicol  (1.85 GBq/mmol; Amersham 
Corp., Arlington Heights,  IL) for 12 h at 37°C.  The organic components 
in the reaction mixture were then extracted with ethyl acetate and separated 
by thin-layer chromatography using 95 % chloroform 5 % methanol as sol- 
vent, and were exposed to x-ray films. Amounts of acetylated ehloramphen- 
icol were  quantitated by exposure to a Bioimaglng  plate (Fujifilm  Inc., 
Tokyo, Japan) for 12 h and analyzed by a Bioimaging  Analyzer (Fujifilm 
Inc.).  To  ensure reproducibility,  experiments were repeated four to six 
times.  To account for variation in cell transfection efficiency, CAT activity 
was normalized against the amount of lueiferase activity (Berthold, 1990). 
Enzymatic assays measuring lueiferase activity were performed in Autolu- 
mat LB953  (Lab.  Prof.  Dr.  Berthold GmbH & Co., Wildbad, Germany) 
using Picagene System (Toyo Ink Co., Tokyo, Japan). 
Preparation of Nuclear Extracts and Electrophoresis 
Mobility Shift Assay (EMSA) 
Nuclear extracts  were prepared essentially as described by Dignam et al. 
(1983). All steps were performed at 4°C. Confluent cells were washed with 
PBS twice,  resusponded  in 10 mM Hepes (pH 7.5),  10 mM KC1, 1.5 mM 
MgC12, 0.5 mM DTT, and the nuclei were isolated with 10 strokes  in a 
Dounce homogenizer.  The nuclei suspension was centrifuged at 2,000 g for 
20 min, and the pellet was resuspended in a buffer C (20 mM Hepes (pH 
7.5), 420 mM NaC1, 1.5 mM MgC12, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 
mM DTT, 25 % (vol/vol) glycerol),  and lysed as described above. The nu- 
clear lysate was centrifuged at 12,000 g for 20 rain, the supernatant was 
dialyzed against a buffer D (20 mM Hepes [pH 7.5], 100 mM KC1, 0.2 mM 
EDTA,  0.5 mM PMSF,  0.5 mM DTT, 20% glycerol)  and centrifuged at 
10,000 g for 5 min. Aliquots of the nuclear extracts were stored at -80°C. 
Oiigonucleotide probes were annealed by heating to 95°C for 5 min followed 
by cooling slowly to room temperature in the presence of 50 mM Tris-HC1 
(pH 8.0) and 10 mM MgCI2. Some sequences also contained cohesive Sail 
sites at the ends. The annealed probes were labeled by filling-in 5' protrud- 
ing ends with [c~-32P]dCTP (New England Nuclear/Du Pont, Wilmington, 
DE) using the Klenow fragment (Pharmaeia, Uppsaia, Sweden) to a specific 
activity greater than l0  s cpm/#g. Approximately  20,000 cpm of the probe 
was incubated with 5 #g of nuclear protein for 20 min at 30°C in 40 t~l reac- 
tion mixture,  containing buffer D, 5/zg of BSA (Sigma Chem. Co.), and 
2 t~g of poly (dI-dC) (Phanuacia, Piscataway, NJ). For competition experi- 
ments, competitor DNAs were incubated with the nuclear extracts  for 20 
min before the addition of the probe.  The DNA-protein complexes  were 
fractionated on a nondenaturing 4% polyaerylamide  gel (aerylamide-bis- 
aerylamide, 29:1) at 11 V/cm for 1.5 h in TAE buffer (0.134 mM Tris-HC1, 
pH 7.5, 0.66 mM CH3COONa,  and 0.2 mM EDTA.2Na)  for EMSA. After 
electrophoresis,  the gels were vacuum-dried and exposed to x-ray film using 
intensifying screens (New  England Nuclear/Du Pont) at  -800C for 12- 
48 h.  The oligunucleotide  sequences used as  probes or competitors in 
EMSA were as follows: 
ES-19, TCGACTTGACCTATTGCGCACATGACCCCG (OCE1 top strand) 
ES-20,  TCGAC~_JC~TCATGTGCGCAATAGGI~_AAG  (OCE1  bottom 
strand) 
ES-5, TCGACGCCTCCGCCCCGGCAGC~GTCG  (OCE2 top strand) 
ES-6,  TCGACGAC'fGCAGCTGCC~GGAGC~G  (OCE2  bottom 
strand) 
ES-7, TCGACCCAGCCAGTGCTCCAGCTGAGC~TG  (OCE3 top strand) 
ES-8,  TCGACAGCCTCAGCTGGAGCACTGGCTGGG  (OCE3  bottom 
strand) 
ES-21, TCGACGGAGGCATTTTCTC.AATI~AGC~TG  (OCFA top strand) 
ES-22,  TCGACAGCCICAATTGAGAAAATGCCTCCG  (OCE4  bottom 
strand) 
ES-1,  TCGACAGAACACCTGCAGCAGCTGGCAGC~  (~E5+uE2  top 
strand) 
ES-2, TCGACCCTGCCAGCTGCTGCAGGTGTTCTG  (/zE5+/~E2 bottom 
strand) 
ES-9, TCGACCCCCCCAACACCTGCTGCCTGAGCCG (MEF1 top strand) 
ES-10, TCGACGCd2TCAGC~AGCAGGTG~  (MEF1 bottom 
strand) 
ARM2S,  TCGACACAATTrTCTCGATTTTCAGGTCTG  (top strand) 
ARM2SR, TCGACAGACGIGAAAATCG'IGAAAATTGTG (bottom strand) 
EM-I, TCGACTTGACCTAT'IV_d2GTGTTACACCCCG  (OCmEI top strand) 
EM-2, TCGACGGC~TGTAACACGCAATAGGTCAAG  (OCmE1  bottom 
strand) 
The glutathion-S-transferase  (GST) and GST-ANId fusion proteins were 
kindly provided by Dr. M. Obinata (Tohoku University, Sendai, Japan). The 
GST-ANId fusion protein was made by insertion of codons 80-176 of mouse 
IdA (Benezra et al., 1990) in frame with GST in the vector pET (Novagen 
Inc., Madison, WI). Purified GST or GST-ANId protein was added to nu- 
clear extracts prepared from ROS17/2.8 cells and denatured by dialysis for 
1 h at 4"C against 6 M guanidine HC1 in buffer D. The extracts were then 
similarly renatured by dialysis against the same buffer without guanidine 
HCI and were used in EMSA as described above. 
RNA Isolation and Northern Blot Analysis 
Total cellular RNA was prepared at the indicated time points by the acid 
guanidium thiocyanate-phenol-chloroform  method as described by Chom- 
czynski and Sacchi (1987). 20 t~g of the total RNA per lane was electropho- 
resed in 1% agarose gels containing 0.66 M formaldehyde  and was trans- 
ferred to a nylon filter (Hybond-N; Amersham Corp.) by electroblotting 
(Thomas,  1980). Filters were UV cross-linked, and prehybridized overnight 
at room temperature in a  buffer  containing 50%  formamide,  5  x  SSC 
(1  x  SSC consists of 0.15 M NaCI and 10 mM sodium citrate), 5  x  Den- 
hardt's solution,  0.1% SDS, and 50 #g/rni sheared and denatured herring 
sperm DNA. Complementary DNA for rat ostooealcin  (Yoon et al., 1987) 
or rat osteopontin (Oldberg et ai., 1986) was excised with EcoRI and sepa- 
rated from vector sequences by Seaplaque gel electrophoresis and then radio- 
labeled by random primer method using Klenow fragment (Pharmacia) and 
[c¢-32P]dCTP (Now England Nuclear/Du Pont) as described by Feinberg 
and Vogelstein (1983). Specific radioactivity of labeled eDNA was  1 to 5 
×  l0  s  cpm/#g  DNA.  Filters  were  hybridized with  32p-labeled eDNA 
probes at 420C for 18 h in a solution containing all ingredients described 
above. Filters were washed in 0.1  x  SSC containing 0.1% SDS for 15 rain 
at 65°C,  and were exposed  to x-ray film using intensifying screens (Now 
England Nuclear/Du Pont) at  -80"C for several  days.  Equal loading  of 
RNA in each lane was checked by ethidium bromide staining. 
Protein 
Recombinant human BMP-2 (Wang et al., 1990) was kindly provided by Dr. 
J. Wozney (Genetics Institute,  Cambridge, MA). 
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Overexpression of  ld-1 Suppresses Osteocalcin Gene 
Promoter Activity 
We first examined the promoter sequence of rat osteocalcin 
gene and  located five sites  of E-box consensus  sequence 
within the 1.1-kb fragment of the 5' flanking region. These 
E-box sequences were designated as OCE1 to OCE5 accord- 
ing to the order of the distance from the transcription start 
site (Fig.  1). To elucidate whether the members of the HLH 
protein family are involved in regulating the activity of os- 
teocalcin gene promoter in  osteoblasts,  we  examined the 
effects  of overexpression of the  trans-donfinant negative 
regulator, Id-1, which lacks the basic region adjacent to HLH 
domain in rat osteoblastic osteosarcoma ROS17/2.8 cells. As 
shown in Fig. 2 A, cotransfection of a sense Id-1 expression 
vector resulted in suppression of the promoter activity (by 
~50%)  of  the  pOC1094CAT,  which  contains  a  1.2-kb 
(-1094/+147) promoter region of rat osteocalcin gene linked 
to a CAT reporter gent (Fig. 2 A, lanes 4 and 5 vs. lanes 6 
and 7). In contrast, cotransfection of  another expression vec- 
tor that carries Id-1 eDNA in reverse (antisense) orienta- 
tion [Idl-AS] increased expression of the CAT activity (by 
~,60%) (Fig. 2 A, lanes 8 and 9). CAT activity data were 
normalized  against  luciferase  activity  to  correct  for  the 
transfection efficiency. Thus, the results of these cotransfec- 
tion experiments suggested the involvement of HLH tran- 
scription  factors  in  regulation  of  osteocaicin  gene  ex- 
pression. 
Deletion and Site-directed  Mutagenesis Analyses of 
the 5"flanking Region of  Rat Osteocalcin Gene 
To locate sequences in the 5'-flanldng region of rat ostcocal- 
cin  gene which mediates M-l-dependent suppression,  we 
constructed a series of CAT reporter constructs, which con- 
tain sequential deletion mutants of the 5"flanking fragment 
placed upstream of  the CAT gene (Fig. 1). The CAT activities 
of the two constructs in which 5' end was deleted up to the 
nucleotide  positions  -432  and  -199  (pOC431CAT  and 
pOC198CAT,  respectively) were suppressed by sense Id-I 
overexpression while they were enhanced by antisense Id-1 
overexpression (Fig.  2,  B  and  C),  similarly to those ob- 
served in the case of pOC1094CAT (Fig. 2 A). In contrast, 
there was neither significant suppression nor enhancement 
in the level of CAT activity when pOC98CAT was cotrans- 
fected with  Id-1 sense or antisense  expression vectors in 
ROS17/2.8  cells (Fig. 2 D).  This deletion analysis implied 
the presence of a transcriptional machinery, which could be 
interfered by Id-1 protein and would regulate the transcrip- 
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Figure 1. Construction of various Y-deletion and site-directed mu- 
tants of rat osteocalcin gene promoter. Numbers at left represent 
the positions of the Y-end nucleotides included in each construct 
relative to the transcription  start  site at position  +1.  E-box se- 
quences, OCE1 to OCE5, are marked by a box. 
Figure 2. Suppression of rat osteocalcin promoter activity by over- 
expression of Id-1. CAT assay was carried out by using the lysates 
prepared from ROS17/2.8 cells cotransfected with 5 pg of reporter 
plasmid and 5 #g of expression vectors containing Id-I cDNA in 
either coding (sense) [Id-lS] or inverted (antisens¢) [Id-IAS] orien- 
tation, or pBluescript SK(+) [pBS] as described in Materials and 
Methods. The DNAs for each cotransfection also include 1/*g of 
pGVC to estimate transfcction efficiency.  Cells were harvested 48 h 
after transfection followed by measurement of CAT and luciferase 
activities. Each lane represents a separate culture of experimental 
group performed in duplicate, pSV2CAT and pSVOCAT served as 
positive and negative controls, respectively (A) pOC1094CAT was 
cotransfected  with pBS, Id-lS, and Id-IAS. (B) pOCA31CAT was co- 
transfected with pBS, Id-lS, and Id-IAS. (C) pOC198CAT was co- 
tmnsfect~ with pBS, Id-lS, and Id-IAS. (D) pOC98CAT was cotrans- 
fected with pBS, Id-lS, and Id-IAS. 
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interaction with the promoter fragment between the nucleo- 
tide positions  -198 and  -100. This 99-bp region contains 
two  E-box sequences (OCE1  and  OCE2)  (Fig.  1),  which 
meet with a consensus sequence (CANNTG), reported to be 
recognized by HLH family proteins. These E-box sequences 
in OCE1  and OCE2  are CACATG  and CAGCTG, respec- 
tively. These E-boxes of osteocalcin promoter might render 
binding sites for transcription factor(s) of HLH family. To 
determine whether these E-box motifs contribute to the pro- 
moter activity of the osteocalcin gene, we introduced muta- 
tions into OCE1 or OCE2 sites in pOC198CAT construct, by 
replacing  CANNTG  sequence to  TGTTAC (Fig.  1).  One 
reporter  construct  with  site-directed  mutation,  pOCI98- 
mE1CAT,  in  which  OCE1  (-102  to  -97)  was  replaced 
showed reduction of basal transcriptional activity by ,~50 % 
(Fig. 3, lanes 5 and 6) compared to the control (Fig. 3, lanes 
3 and 4). In contrast, the transcriptional activity of another 
mutation construct, pOC198mE2CAT, in which OCE2 (-149 
to -144) was replaced, was similar to that of pOC198CAT 
(Fig. 3, lanes 7 and 8), suggesting that the OCE1  sequence 
but not OCE2 sequence would be necessary for basal tran- 
scriptional activity of the osteocalcin gene. The level of CAT 
activity of pOC198mE2CAT but not pOC198mE1CAT was 
suppressed by Id-lS overexpression and enhanced by Id-IAS 
overexpression, similarly to those observed in the case of 
pOC198CAT (data not shown). 
Interaction of Nuclear Protein(s) with the OCEI Motif 
of Osteocalcin Gene Promoter 
In order to examine the binding activity of nuclear proteins 
which interact with OCE1  sequence, we performed EMSA 
using OCE1 as a probe. Incubation of the OCE1 probe with 
ROS17/2.8 nuclear extracts formed two major retarded bands 
migrating as a doublet (Fig. 4 A, lane 2) which were com- 
peted by the excess amount of unlabeled OCE1 probe (lanes 
3  and 4).  The inability of an unrelated ARM-2  sequence 
(Noda et al.,  1990) to compete against the binding revealed 
the  sequence-specific  binding  in  the  formation  of these 
DNA/protein complexes (Fig. 4, lane 9). Even the presence 
of a  500-fold molar excess of the mutant oligonucleotide 
OCmE1, in which TGTTAC sequence substituted for CAC- 
Figure 3. Effects of mutagene- 
sis in E-box sequences on CAT 
activity  in  ROS17/2.8 cells. 
Substitution  mutations  were 
introduced into either E-box, 
OCE1 or OCE2,  in pOCI98- 
CAT to give rise to pOC198- 
mE1CAT  and  pOC198mE2- 
CAT, respectively,  as described 
in the legend to Fig. 1 and Ma- 
terials  and  Methods.  These 
constructs  were  transfeeted 
into ROS17/2.8 cells, and cell 
extracts  were prepared  48  h 
after  transfection  and  were 
processed for CAT assays as 
described  in  Materials  and 
Methods.  Each  lane,  except 
lanes  1  and  2,  represents  a 
separate experiment of a cul- 
ture well performed in dupli- 
cate.  pSV2-CAT and  pSV0- 
CAT data are served  as positive 
and negative controls, respec- 
tively. 
Figure 4. Electrophoresis mobility shift assay of OCEl-binding ac- 
tivity  in ROS17/2.8 cells.  ROS17/2.8 nuclear  extracts  were  in- 
cubated with indicated amounts of  unlabeled double stranded com- 
petitor oligonueleotides or vehicle (A, lane 2 and B, lane 2) in a 
buffer described in Materials and Methods for 20 min at room tem- 
perature. Radiolabeled OCEI probe (20,000 clam) was then added 
to  these  extracts,  and  protein-DNA  complex  was  resolved by 
EMSA as described in Materials and Methods. The fold excess of 
the amount of competitor relative to the probe is shown above each 
lane (A and B). Lane I shows probe alone without nuclear extracts 
(A and B). The competitor was used at a 500-fold molar excess (C). 
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that of the E-box motif is crucial in the protein-DNA interac- 
tion (Fig. 4 A, lanes 7 and 8). Furthermore, no binding ac- 
tivity  in  ROS17/2.8  nuclear  extracts  was  observed  when 
OCmE1 was used as a probe (data not shown).  In order to 
determine whether the DNA-binding proteins in the crude 
nuclear extracts prepared from ROS17/2.8 cells specifically 
interact with OCE1 site rather than OCE2, we performed an- 
other  competition  assay.  Competition  was  not  observed 
when a 500-molar excess of unlabeled OCE2 oligonucleo- 
tide was included in the binding reaction (Fig. 4 A, lanes 5 
and 6),  suggesting that only OCE1  is the crucial E-box se- 
quence  in  the  198-bp  osteocalcin  gene  promoter.  These 
findings are consistent with the results of the site-directed 
mutation analyses, where mutation in OCE1 but not OCE2 
decreased basal transcriptional activity of the 198-bp rat os- 
teocalcin gene promoter as well as its response to Id-1 over- 
expression. 
The  specificity of the  binding  of the  nuclear  factors to 
OCE1 sequence was further examined in competition assays 
in  which  previously  characterized  binding  sites  for other 
HLH proteins were used as competitor DNAs.  The DNA- 
protein complex formation using ROS17/2.8 nuclear extracts 
and the OCE1 probe was not competed out by the presence 
of an excess amount of a cold oligonucleotide sequence,/~E5 
+  #E2, which consists of original binding sites for E2A gene 
products,  El2 and E47,  identified to bind immunoglobulin 
heavy chain enhancer (Fig. 4 B, lanes 4, 5, and 6) (Henthorn 
et al.,  1990).  Therefore, although El2 and E47 are known 
to be ubiquitously expressed bHLH proteins, protein com- 
plexes which interact with OCE1  would not likely include 
dimers of E12/E47 proteins. Furthermore, another oligonu- 
cleotide sequence, MEF1 (muscle enhancer factor 1), which 
was identified as a binding site for MyoD/EI2 heterodimer 
in muscle creatine kinase enhancer (Buskin and Hauschka, 
1989),  did  not  compete  against  the  binding  activity  in 
ROS17/2.8  nuclear  extracts  to  the  OCE1  sequence  either 
(Fig. 4  B,  lanes  7,  8,  and 9). 
Further  support  for OCE1  sequence-specific binding  of 
nuclear factor(s) in ROS17/2.8 cells was provicied by compe- 
tition assay using other E-box sequences in the osteocalcin 
promoter.  Competition was not observed when a  500-fold 
molar excess of unlabeled oligonucleotides containing OCE3 
(CAGCTG at  -281) or OCE4 (CAATTG at  -553) was in- 
cluded in the binding reaction (Fig. 4  C).  Thus, it appears 
that the preference for the two intervening nucleotides in the 
E-box in  the  case  of OCE1  sequence  could be  C  and  A 
(CACATG). 
The OCE1 Binding Activity Is Dependent on 
Osteoblastic Differentiation 
To examine further the relationship between the OCE1 bind- 
ing activity and osteoblastic differentiation,  we performed 
EMSA using a cell culture model of osteoblastic differentia- 
tion.  A  pluripotent  fibroblastic cell  line,  C3H10T1/2,  was 
chosen for this experiment and was treated with rhBMP-2 to 
induce differentiation. As shown in Fig. 5 A, mRNA expres- 
sion  of genes  encoding  osteocalcin  and  osteopontin,  two 
phenotype-related proteins of osteoblasts, was not detected 
in control C3H10TI/2 cells in Northern blot analysis (lane/). 
After treatment  with  rhBMP-2  (500  ng/ml)  for 72  h,  os- 
Figure 5.  Effects of rhBMP-2 
on osteocalcin mRNA expres- 
sion and OCEl-binding  activ- 
ity in the  nuclear  extracts of 
C3H10TU2 cells. (A) Effect of 
rhBMP-2  on osteocalcin  and 
osteopontin  mRNA  expres- 
sion in C3H10TI/2 ceils. Total 
RNA was isolated after 72 h 
treatment  of  the  ceils  with 
500  ng/ml of rhBMP-2,  and 
Northern  blot  analysis  was 
carried  out  as  described  in 
Materials and Methods. Equal 
loading of RNA in each lane 
was checked by ethidium bro- 
mide  staining  (data  not 
shown). Positions of osteocal- 
cin  mRNA,  osteopontin 
mRNA, 28S, and  18S rRNA 
are  indicated.  (B)  Effect  of 
rhBMP-2  on  OCEl-binding 
activity  in  the  nuclear  ex- 
tracts of C3H1OI'I/2  ceils esti- 
mated by EMSA. Nuclear ex- 
tracts  were  prepared  from 
C3HlffI'I/2  cells treated for 72 
h with 500 ng/ml of rhBMP-2 
Oanes 4 and 5) and nontreated 
control  cells  (lanes  2  and 
3)  and  were  incubated  with 
radiolabeled  OCE1  probe 
(20,000  epm)  followed  by 
EMSA  as  described  above. 
For competition experiments, 
indicated  molar  excess  of 
unlabeled  double  stranded 
OCE1  competitor DNA was 
incubated with the nuclear ex- 
tracts for 20 min prior to the 
addition of the probe.  Lane 1 
contains probe alone with no 
nuclear extract. (C) Competi- 
tive binding assay using mu- 
tant  OCE1  oligonucleotide. 
rb.BMP-2-treated  C3H10TI/2 
nuclear extracts (lanes 2, 3, 4, 
and 5) or ROS17/2.8 nuclear 
extracts  (lane  1)  were  in- 
cubated with unlabeled OCE1 
(lane 3), OCmE1 (lanes 4 and 
5) or vehicle (lanes I and 2) in a buffer as described above. Radio- 
labeled OCE1 probe (20,000 cpm) was then added to these extracts, 
and protein-DNA complexes were resolved by EMSA. The fold ex- 
cess of the amount of competitor is shown above each lane. Arrow 
indicates OCEl-specific protein-DNA complex. 
teocalcin,  and osteopontin mRNA expression was induced 
(Fig.  5  A,  lane  2),  indicating  that  C3HIOTI/2 fibroblasts 
would differentiate into osteoblasts (like-cells) in vitro. The 
binding  activity of OCEI  in  the nuclear extracts prepared 
from control C3H10T1/2 cells was very low (Fig. 5 B, lane 
2). In contrast, the OCEl-binding activity in the nuclear ex- 
tracts prepared from C3H1OI'I/2 cells treated with rhBMP-2 
was significantly increased (Fig. 5 B, lane 4).  The mobility 
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tracts was similar to those observed in the case of ROS17/2.8 
nuclear extracts (Fig. 5 C, lane/). Also, similar to the ROS 
17/2.8  nuclear extracts,  the complex formation was  com- 
peted out by an excess amount of unlabeled OCE1 (Fig. 5 C, 
lane 3), but not OCmE1 (lanes 4 and 5), showing the spec- 
ificity of the binding. It is thus possible that similar proteins 
in both ROS17/2.8  cells and rhBMP-2-treated C3H10TI/2 
cells would bind to OCE1. These findings suggest that high 
OCEl-binding activity in the nuclear extracts is present spe- 
cifically in osteoblasts but not in fibroblasts and its induction 
is in close correlation to the differentiation of osteoblasts. 
OCEl-binding Activity Can Be Blocked by 
GST-Id-1 Protein 
To  examine  directly  whether  the  DNA-protein  complex 
formed with OCE1 contains HLH family proteins, we tested 
whether the DNA-binding activity can be blocked by addi- 
tion of the bacterially expressed Id-1 protein to the reaction 
mixtures. Either GST-Id-1 fusion protein or GST alone was 
added to the ROS17/2.8  nuclear extracts before addition of 
the OCE1 probe. When GST-Id-1 protein was not denatured 
with guanidine-HC1, the addition of the protein did not affect 
formation of the DNA-protein complexes between ROS17/ 
2.8 nuclear extracts and OCE1 (Fig. 6 B). On the other hand, 
when GST-Id-1 or GST was added to ROS17/2.8 nuclear ex- 
tracts after denaturation with 6 M guanidine-HCl and rena- 
turating, GST-Id-1 but not GST itself blocked the binding to 
OCE1 in a dose dependent manner (Fig. 6 A). These findings 
suggest that OCEl-binding proteins in ROS17/2.8 nuclear ex- 
tracts would be heterodimers or homodimers of HLH pro- 
teins whose DNA-binding activity could be interfered by the 
presence of monomeric Id-1 protein. 
Figure 6.  GST-Id-1 protein  suppresses OCEl-binding activity in 
osteoblast-like ceils. (A) Either bacterially expressed GST or GST- 
ANId-I (GST-Id-1)  proteins at the indicated doses were added to 5 
/~g of nuclear extracts prepared  from ROS17/2.8 cells and were 
denatured for 1 h at 4°C by dialysis against 6 M guanidine HCI in 
a buffer D. The extracts were then renatured by dialysis against the 
same buffer without guanidine HC1. The extracts were then used 
for EMSA as described above. (B) Bacterially expressed GST or 
GST-ANId-1 (GST-Id-1) protein at the indicated doses were added 
to 5 ~g of nuclear extracts prepared from ROS17/2.8 ceils without 
denaturation and renaturation. The extracts were then subjected to 
EMSA as described  above. Arrows indicate OCEl-specific pro- 
tein-DNA complexes. 
Discussion 
Osteoblastic differentiation is a complex process of a series 
of time dependent expression of genes encoding phenotype- 
related proteins  (for reviews see Rodan and Noda,  1991; 
Stein and Lian, 1993). Although responsive elements of sev- 
eral calcitropic regulators have been located in the promoter 
regions of these genes (for review see Young et al.,  1993), 
DNA sequence(s) and the cognate transcription factor(s) in- 
volved  in  molecular  interaction  underlying  osteoblastic 
differentiation have not yet been identified.  Production of 
bone and bone matrix proteins, such as osteocalcin, type I 
collagen, osteopontin, bone sialoprotein, osteonectin and so 
on, is a specific function of osteoblasts and it is regulated at 
least  in  part,  at  transcriptional  levels  (Rodan and  Noda, 
1991). Among these proteins, osteocalcin is the only known 
specific product of differentiated osteoblasts. Therefore, we 
examined the promoter region of the osteocalcin gene in or- 
der to identify sequence(s) involved in osteoblast-specific 
transcription and hence required for osteoblast-specific ex- 
pression.  Our results presented in this report demonstrate 
that osteocalcin gene transcription in osteoblast is regulated 
via interaction between an E-box, which we call OCE1, in 
the promoter region and certain osteoblastic E-box-binding 
transcription factor(s). 
bHLH proteins are involved in cell type determination and 
differentiation through their transcriptional activation of a 
repertoire of subordinate genes, bHLH proteins bind to the 
CANNTG motif  as either homo- or heterodimers (for review 
see Murre and Baltimore, 1992). Dominant negative type of 
HLH proteins such as Id-1, Id-2, HLH462, and emc which 
lack the basic DNA-binding domain have been shown to bet- 
erodimerize with bHLH proteins to make them unable to 
bind to DNA (Benezra et al., 1990; Chiristy et al., 1991; Sun 
et al., 1991; Biggs et al., 1992). Id-1 appears to be expressed 
ubiquitously, and Id-1 mRNA expression has been observed 
in osteoblasts in cultures. Furthermore, IdA gene expression 
is regulated by various calcitropic agents in osteoblasts or 
osteoblast-like cells (Ogata and Noda,  1991; Kawaguchi et 
al.,  1992).  However, the  functional significance of HLH 
family transcription factors have not yet been implicated in 
transcriptional regulation of any genes including osteocalcin 
gene in osteoblasts. We found that overexpression of Id-1 re- 
duced  transcriptional  activity of the  1,094-bp osteocalcin 
promoter. Recent studies also demonstrated that similar Id-1 
overexpression suppresses  transcriptional  activity  of IgH 
and Igr genes in mature B cells (Wilson et al., 1991), insulin 
gene in pancreatic ~-cell (Cordle et al., 1991), and pro-opio- 
melanocorcin gene in pituitary cells (Therrien and Drouin, 
1993).  We also  observed cotransfection of antisense Id-1 
vector-enhanced transcriptional activity of the osteocalcin 
gene promoter. This would be due to the inactivation of the 
constitutively expressed Id-1 mRNA in ROS17/2.8 cells. De- 
letion analysis of the osteocalcin promoter region indicated 
that  transcriptional  modulation by Id-1  of rat osteocalcin 
gene promoter activity is mediated via a cis-active regula- 
tory region between -198 and -98. Lian et al. (1989) have 
identified in the proximal promoter region of rat osteocalcin 
gene a  24-nucleotide sequence, designated as "osteocalcin 
box (-99 to -74)," which contains a CCAAT motif as a cen- 
tral  element,  and  contributes to  the  basal  transcriptional 
activity of osteocalcin gene. The promoter fragment,  -198 
Tamura and Noda  A DNA Sequence Involved in Osteoblastic Differentiation  779 to  -98, in the rat osteocalcin gene contains two E-box se- 
quences, OCE1 and OCE2, that suffice the consensus require- 
ment.  The introduction  of mutation into OCE1 (pOC198m- 
E1CAT) but not in OCE2 (pOCI98mE2CAT)  reduced the 
basal transcriptional  activity of the osteocalcin gene.  Fur- 
thermore,  CAT activity of only pOC198mE2CAT  but not 
pOC198mE1CAT was suppressed by sense Id-1 overexpres- 
sion and enhanced by antisense IdA overexpression  to a de- 
gree similar to those observed in the case of pOC198CAT 
(data not shown).  Markose et al. (1990) reported the pres- 
ence of protection in osteocalcin box juxtaposed to OCE1 by 
DNase I footprinting analysis. In competition binding assay, 
the protein complexes interacting  with OCE1 site were not 
competed out by other E-boxes in osteoealcin gene promoter, 
OCE2 (CAGCTG), OCE3 (CAGCTG), or OCE4 (CAATTG). 
Thus, the OCE1 with CACATG type E-box motif represents 
a novel regulatory element of osteocalcin gene and would 
play a unique role in the regulation  of osteocalcin promoter 
activity  and  osteoblast-specific  expression  of the  rat  os- 
teocalcin gene.  This notion is also supported by our paral- 
leled experiments,  where osteocalcin mRNA expression was 
suppressed significantly in ROS17/2.8 cells which were per- 
manently  transfected  with  sense Id-1 vector (unpublished 
results). 
OCEl-binding activities were present in nuclear extracts 
prepared from ROS17/2.8 cells. The protein complexes inter- 
acting with OCE1 site were not competed out by OCE2 oli- 
gonucleotide or by the mutant oligonucleotide,  OCmE1, in 
which  TGTTAC  sequence  was  substituted  for  CACATG. 
These results  suggested that OCEl-binding activity may be 
required for the transcriptional  activities of rat osteoealcin 
promoter.  We and others have observed that  HLH mole- 
cules, such as E12/E47 and mTwi, the murine homologue of 
the Drosophila twist, are expressed in osteoblasts or osteo- 
blast-like cells (Noda, M., unpublished observation; Murray 
et al., 1992). However, the levels ofE12/E47 mRNA expres- 
sion do not appear to change during differentiation  of osteo- 
blasts. Murray et al. (1992) demonstrated that mTwi mRNA 
expression declined with osteoblastic maturation  in mouse 
osteoblastic cell line MC3T3E1 like Id-1 mRNA expression 
(Ogata and Noda,  1991). Therefore,  the protein complexes 
which interact  with  OCE1  would not likely include these 
known HLH molecules. In our competition assays (Fig. 4), 
previously characterized  HLH protein  binding  sites were 
used as competitor DNAs, such as the oligonucleotide se- 
quence,/~E5 +/zE2, which consists of original binding sites 
for E2A gene products El2 and FA7 (Henthorn et al., 1990), 
and MEFI, which was identified as a MyoD/E12 heterodimer 
binding site in muscle creatine kinase enhancer (Braun et al., 
1989). The failure of competition by these sequences suggest 
that dimers of widely distributed E12/E47 proteins or muscle- 
specific regulatory protein heterodimer (MyoD/E12)  would 
not consist of the protein  complexes which interact  with 
OCE1 in ROS17/2.8 cells. We also examined the possibility 
that OCEl-binding proteins may share epitopes with other 
HLH proteins by using an antiserum against human El2 and 
E47 proteins (gifts from Dr. C. Murre, Whitehead Institute 
for Biomedical Research, Cambridge,  MA) (Murre et al., 
1989) in EMSA. The OCEl-binding activity in ROS17/2.8 
ceils was not reduced or supershifted by the presence of the 
antiserum (unpublished  observations). Therefore,  the bind- 
ing complexes which interact with OCE1 would include pro- 
teins other than E12/E47  heterodimer or homodimer. 
BMP-2 is sufficient by itself to induce ectopic bone forma- 
tion  in  vivo (Wozney et al.,  1988).  BMP-2  was  recently 
reported to induce osteoblastic differentiation and to upregu- 
late the expression of most of  the genes encoding osteoblastic 
phenotype-related proteins in  vitro.  Katagiri  et al.  (1990) 
reported that  the level of alkaline  phosphatase mRNA ex- 
pression and enzyme activity were increased in C3H10TI/2 
cells by the treatment  with rhBMP-2.  Our experiment indi- 
cated that the treatment  with rhBMP-2  also induced osteo- 
calcin and osteopontin mRNA expression  as demonstrated 
by Northern blot analysis (Fig. 6 A). OCEl-binding  activity 
in C3H10T1/2 nuclear extracts was very low, however it was 
markedly increased by the treatment with  rhBMP-2.  Fur- 
thermore, the size of the OCEl-binding complexes in C3H- 
10T1/2 nuclear extracts treated with rhBMP-2 was similar to 
that of the ROS17/2.8 cells nuclear extracts judging from the 
mobility in EMSA. These results do not contradict the idea 
that  OCEl-binding  protein(s)  may  be  involved  in  osteo- 
blast-specific  transcription  of osteocalcin gene. 
The best-characterized  members of the bHLH family in- 
volved in mammalian  cell differentiation  are the myogenic 
transcription  factors including MyoD (Lassar et al.,  1989), 
myogenin  (Wentworth  et al.,  1991), Myf-5 (Braun  et al., 
1989), and MRF4 (Rhodes and Konieczny,  1989).  Expres- 
sion of these proteins has been implicated in both cell type 
determination  and differentiation  in skeletal  muscle cells. 
Forced expression  of these proteins converts nonmyoblastic 
cells such as fibroblasts  into myocytes (Davis et al.,  1987; 
Weintraub et al., 1989). "Loss of function ~ experiments with 
myogenin gene are lethal perinataily due to the major defects 
in skeletal  muscle as demonstrated using homologous re- 
combination  techniques  (Hasty et al.,  1993;  Nabeshima 
et al.,  1993).  In central  and peripheral  nervous systems, 
MASH proteins (mammalian  homologues of achaete-scute 
gene) have been suggested to play critical roles in neurogene- 
sis (Johnson  et al.,  1992).  The other bHLH protein, SCL, 
is  expressed during  early hematopoiesis and possesses a 
differentiation-related  DNA-binding  motif (Visvader  and 
Begley,  1991). The observation that myeloid differentiation 
can be inhibited by overexpression  of Id-1 implies an impor- 
tant role for the bHLH factors in this lineage of cells as well 
(Kreider et al.,  1992).  Efficient osteoblast-specific  expres- 
sion of osteocalcin gene may require an OCE1 sequence that 
bind to transcription  factor(s) expressed specifically  in os- 
teoblast as well as bHLH proteins which are expressed ubiq- 
uitously in many cell types. The suppression  of osteocalcin 
promoter activity due to Id-I overexpression  and the inhibi- 
tion of the OCEl-binding  activity in ROS17/2.8 cells by the 
addition of GST-Id-1 further support the idea that HLH fac- 
tors are involved in osteocalcin gene expression.  Thus, in ad- 
dition  to the role of HLH molecules in  skeletal  muscle, 
adipocyte, pancreas,  and lymphocyte, this study provides an 
evidence for a possibility that certain HLH factors are in- 
volved in osteoblast-specific  gene transcription  and osteo- 
blastic differentiation.  If such osteoblast-specific HLH tran- 
scription  factors  exist,  these  factors  may be involved  in 
osteoblast differentiation  in general in addition  to acting as 
transcription  factors  for osteocalcin gene.  Our  on-going 
studies  are  aimed  at  identifying  these osteoblast-specific 
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